X Financial (XYF) Q4 2025 Earnings Call Prepared Remarks Transcript

X Financial held its Q4 2025 earnings call on March 26, 2026 and released financial results for the quarter and fiscal year ended Dec 31, 2025 (available on the company's IR site). Management (President Kan Li, CFO Frank Fuya Zheng, Chief Financial Strategy Officer Noah Kauffman) outlined an agenda covering business performance, the regulatory environment, fourth-quarter results, capital position and outlook, but this excerpt contains no specific financial metrics or guidance. The company reiterated standard forward-looking statements and risk disclosures referencing SEC filings.

Analysis

The regulatory overhang that dominates sentiment here disproportionately favors scale and capitalized balance sheets. That creates a two-speed market: large platform lenders and onshore banks can restore access to institutional funding and securitization conduits within 3–12 months, while smaller, asset-light fintechs will face permanently higher marginal funding costs and a slower amortization of acquisition costs. Expect a compression of exit valuations for small originators and a meaningful pick-up in M&A activity as well-capitalized buyers acquire borrower pools at distressed yields.

A key second-order channel is the securitization/ABS investor base: if credit enhancement levels or on-balance liquidity buffers are tightened by regulators, external buyers will demand 150–300bp wider spreads on new issuance, translating into a 20–60% drop in incremental ROE for originators that rely on cheap warehouse funding. Funding mix sensitivity to FX (dollar-funded lines) means a moderate CNY move or US rate shock could increase cost of funds within weeks, not quarters, flipping near-term profitability assumptions. Monitor ABS primary volumes, warehouse utilization, and agency guidance as high-frequency proxies for stress.

Tail risks cluster around a regulatory shock (new capital adequacy/test rules) or a rapid NPL reclassification that forces immediate loss recognition — both can cut equity value by north of 50% within months. Conversely, if management secures committed onshore funding or a backstop ABS buyer, recovery could be swift and non-linear: equity could rerate 30–70% within 6–12 months as leverage and ROE normalize. The path is binary; size and source of new capital are the primary catalysts that will resolve the uncertainty.

Key Decisions for Investors

• Short XYF via options: buy 3–6 month ATM puts (or a 3–6 month put spread to limit premium) immediately, sizing to 1–2% portfolio risk; thesis: 30–50% downside if funding costs reprice or ABS market shrinks; stop-loss: exit if XYF issues committed onshore funding or posts ABS demand recovery within 45 days.
• Pair trade (6–12 months): short XYF equity vs long LU (Lufax, NYSE: LU) — go 1:1 dollar exposure. Rationale: larger, better-capitalized platforms with onshore bank partners should outperform smaller originators as regulation favors scale; target differential outperformance 30–50%, max drawdown capped by pair sizing.
• Event/volatility trade: buy 9–12 month out-of-the-money puts on XYF as insurance (costly but asymmetrical). Use as tail hedge against regulatory reclassification or sudden NPL recognition; if no shock occurs, let theta decay but roll down into shorter-dated protection ahead of key regulatory/ABS calendar events.